COMBIPHAR was founded in 1971 and is a leading pharmaceutical company in Indonesia, now evolving into a modern consumer healthcare company. It produces and markets over 200 prescription and over-the-counter products, including OBH Combi cough syrup, Insto eye-care solution, and JointFit gel-based relief for joints. The company is equipped with the latest production technology and has obtained Therapeutic Goods Administration (TGA) Certification, enabling exports to Australia. Additionally, COMBIPHAR has a dedicated Research & Development facility focusing on quality optimization and nanotechnology.
COMBIPHAR has been recognized as the 2nd most reputable healthcare brand in Indonesia, highlighting its strong brand equity, customer loyalty, and exceptional customer experience. The company's manufacturing plant in Padalarang, West Java, adheres to the highest professional operation standards, ensuring the production of high-quality healthcare products.
With a workforce of 1,146 employees, COMBIPHAR is headquartered in South Jakarta, Indonesia, and operates as a Perseroan Tertutup. The company's commitment to innovation and quality has solidified its position as a trusted name in the pharmaceutical and consumer healthcare sectors.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Private Company |
B2B professionals should contact COMBIPHAR for partnerships in the pharmaceutical and consumer healthcare sectors, leveraging its innovative products and strong market presence. The company offers opportunities for vendor collaborations and access to a reputable brand with a proven track record.
Sales teams targeting the pharmaceutical and consumer healthcare industries, recruiters seeking roles in R&D and manufacturing, and partners interested in quality optimization and nanotechnology should reach out to COMBIPHAR.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with COMBIPHAR